Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Recommendation of "Hold" from Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has received a consensus rating of "Hold" from the seven analysts that are covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $7.9167.

A number of research analysts have issued reports on AVAH shares. Jefferies Financial Group raised shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and dropped their target price for the company from $6.25 to $6.00 in a report on Monday, July 21st. Barclays upgraded Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. UBS Group upgraded Aveanna Healthcare from a "sell" rating to a "neutral" rating and lifted their price objective for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. Finally, Raymond James Financial upgraded Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 price objective for the company in a research report on Monday, August 11th.

Aveanna Healthcare Stock Down 1.6%

Shares of NASDAQ:AVAH opened at $8.81 on Friday. The company has a market cap of $1.84 billion, a P/E ratio of 110.13 and a beta of 2.05. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $9.11. The company has a 50-day moving average price of $7.65 and a 200 day moving average price of $5.83.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last issued its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. The company had revenue of $450.53 million during the quarter. Analysts expect that Aveanna Healthcare will post -0.06 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AVAH. Summit Partners L P purchased a new stake in Aveanna Healthcare in the 2nd quarter worth approximately $50,477,000. Assenagon Asset Management S.A. purchased a new stake in Aveanna Healthcare in the 3rd quarter worth approximately $7,356,000. First Eagle Investment Management LLC grew its stake in Aveanna Healthcare by 12.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 810,667 shares of the company's stock worth $4,240,000 after acquiring an additional 87,500 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its stake in Aveanna Healthcare by 103.9% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 664,890 shares of the company's stock worth $3,477,000 after acquiring an additional 338,746 shares during the period. Finally, Squarepoint Ops LLC grew its stake in Aveanna Healthcare by 207.0% in the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock worth $2,510,000 after acquiring an additional 323,656 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.